Notice from the Office of the Secretary: The Special Committee of The Board of Directors of Cannimed Therapeutics Inc. and Aurora Cannabis Inc., File No. 2017-73
For Immediate Release
THE SPECIAL COMMITTEE OF THE BOARD OF DIRECTORS OF CANNIMED THERAPEUTICS INC. and AURORA CANNABIS INC., File No. 2017-73
TORONTO – On December 12, 2017, the Commission issued a Notice of Hearing pursuant to Sections 104 and 127 of the Securities Act, RSO 1990, c S.5 to consider the Amended Application filed by the Special Committee of the Board of Directors of CanniMed Therapeutics Inc. (“CanniMed”), on behalf of CanniMed, dated December 11, 2017 in respect of a request for an order that, along with related relief, Aurora Cannabis Inc., SaskWorks Venture Fund Inc., Apex Investments Limited Partnership, Golden Opportunities Fund Inc., and Vantage Asset Management Inc. are deemed to be joint actors, as defined in Multilateral Instrument 61-101 Protection of Minority Shareholders in Special Transactions, and are acting jointly or in concert in connection with the unsolicited take-over bid to acquire all of the issued and outstanding common shares in the capital of CanniMed made by Aurora Cannabis Inc. pursuant to its take-over bid circular dated November 24, 2017.
The hearing will be held on December 20, 2017 at 9:00 a.m. at 20 Queen Street West, 17th Floor, Toronto, Ontario.
A copy of the Notice of Hearing dated December 12, 2017 and the Amended Application dated December 11, 2017 are available at www.osc.gov.on.ca.
OFFICE OF THE SECRETARY
GRACE KNAKOWSKI
SECRETARY TO THE COMMISSION
| For media inquiries: media_inquiries@osc.gov.on.ca |
||
| For Investor Inquiries: | OSC Contact Centre 416-593-8314 1-877-785-1555 (Toll Free) |